The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2509-2723
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial ; volume:45 ; number:1 ; day:8 ; month:12 ; year:2022 ; pages:29-43 ; date:2.2023
GeroScience ; 45, Heft 1 (8.12.2022), 29-43, 2.2023
- Urheber
-
Yi, Lin
Maier, Andrea B.
Tao, Rongsheng
Lin, Zhigang
Vaidya, Aditi
Pendse, Sohal
Thasma, Sornaraja
Andhalkar, Niranjan
Avhad, Ganesh
Kumbhar, Vidyadhar
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s11357-022-00705-1
- URN
-
urn:nbn:de:101:1-2023040521472618098338
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:46 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Yi, Lin
- Maier, Andrea B.
- Tao, Rongsheng
- Lin, Zhigang
- Vaidya, Aditi
- Pendse, Sohal
- Thasma, Sornaraja
- Andhalkar, Niranjan
- Avhad, Ganesh
- Kumbhar, Vidyadhar
- SpringerLink (Online service)
Ähnliche Objekte (12)
Protocol of a randomized, double-blind, placebo-controlled, parallel-group, multicentre study of the efficacy and safety of nicotinamide in patients with Friedreich ataxia (NICOFA)
Oral nicotinamide provides robust, dose-dependent structural and metabolic neuroprotection of retinal ganglion cells in experimental glaucoma
Effect of nicotinamide riboside on airway inflammation in COPD: a randomized, placebo-controlled trial
NAA1: Nicotinamide Riboside Supplementation Reduces Aortic Stiffness and Blood Pressure in Middle-Aged and Older Adults
Acute dose-dependent effects of mescaline in a double-blind placebo-controlled study in healthy subjects
Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults
Varenicline and counseling for vaping cessation: a double-blind, randomized, parallel-group, placebo-controlled trial
Effects of egg yolk choline intake on cognitive functions and plasma choline levels in healthy middle-aged and older Japanese: a randomized double-blinded placebo-controlled parallel-group study
Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects
Coffee break has no impact on laparoscopic skills: a randomized double-blinded placebo-controlled parallel-group trial
Oral nicotinamide mononucleotide (NMN) to treat chronic insomnia: protocol for the multicenter, randomized, double-blinded, placebo-controlled trial
Dose-dependent effect of caffeine supplementation on judo-specific performance and training activity: a randomized placebo-controlled crossover trial
Protocol of a randomized, double-blind, placebo-controlled, parallel-group, multicentre study of the efficacy and safety of nicotinamide in patients with Friedreich ataxia (NICOFA)
Oral nicotinamide provides robust, dose-dependent structural and metabolic neuroprotection of retinal ganglion cells in experimental glaucoma
Effect of nicotinamide riboside on airway inflammation in COPD: a randomized, placebo-controlled trial
NAA1: Nicotinamide Riboside Supplementation Reduces Aortic Stiffness and Blood Pressure in Middle-Aged and Older Adults
Acute dose-dependent effects of mescaline in a double-blind placebo-controlled study in healthy subjects
Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults
Varenicline and counseling for vaping cessation: a double-blind, randomized, parallel-group, placebo-controlled trial
Effects of egg yolk choline intake on cognitive functions and plasma choline levels in healthy middle-aged and older Japanese: a randomized double-blinded placebo-controlled parallel-group study
Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects
Coffee break has no impact on laparoscopic skills: a randomized double-blinded placebo-controlled parallel-group trial
Oral nicotinamide mononucleotide (NMN) to treat chronic insomnia: protocol for the multicenter, randomized, double-blinded, placebo-controlled trial
Dose-dependent effect of caffeine supplementation on judo-specific performance and training activity: a randomized placebo-controlled crossover trial
Protocol of a randomized, double-blind, placebo-controlled, parallel-group, multicentre study of the efficacy and safety of nicotinamide in patients with Friedreich ataxia (NICOFA)
Oral nicotinamide provides robust, dose-dependent structural and metabolic neuroprotection of retinal ganglion cells in experimental glaucoma
Effect of nicotinamide riboside on airway inflammation in COPD: a randomized, placebo-controlled trial
NAA1: Nicotinamide Riboside Supplementation Reduces Aortic Stiffness and Blood Pressure in Middle-Aged and Older Adults
Acute dose-dependent effects of mescaline in a double-blind placebo-controlled study in healthy subjects
Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults
Varenicline and counseling for vaping cessation: a double-blind, randomized, parallel-group, placebo-controlled trial
Effects of egg yolk choline intake on cognitive functions and plasma choline levels in healthy middle-aged and older Japanese: a randomized double-blinded placebo-controlled parallel-group study
Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects
Coffee break has no impact on laparoscopic skills: a randomized double-blinded placebo-controlled parallel-group trial
Oral nicotinamide mononucleotide (NMN) to treat chronic insomnia: protocol for the multicenter, randomized, double-blinded, placebo-controlled trial